Connecting industry leaders
The SCDM Leadership Forum is an annual strategic event for Clinical Data Management (CDM) & Regulatory leaders. It provides participants with a unique opportunity to share and discuss strategic insights while making lasting connections and engaging with peers.
The SCDM Leadership Forum is an annual strategic event for Clinical Data Management (CDM) & Regulatory leaders. It provides participants with a unique opportunity to share and discuss strategic insights while making lasting connections and engaging with peers.
This year’s Leadership Forum in San Diego will explore how emerging AI/ML capabilities can disrupt and empower the change towards Clinical Data Science. Throughout the day, we will delve into the most pressing questions shaping our industry and discuss the impact – over the next 5 years – of AI/ML on people, the regulatory landscape, technology and processes.
Discover the topics
Participants will have the opportunity to engage and, together with fellow industry leaders, address thought-provoking topics including:
-
The untapped potential of Generative AI
-
Leveraging AI to detect and combat fraud
-
Navigating risks: the dark side of (Generative) AI
-
Balancing innovation and ethics to preserve data protection and privacy
-
Recruiting, developing and educating talent towards organizational transformation
-
Separating hype from reality
Technology
Ward Lemaire, Head of Data Management, J&J
What is AI/ML? How is their implementation shaping and evolving other industries and how do we distinguish hype from reality in its implementation in Clinical Data Management?
Process
Catherine Célingant, Executive Director, Clinical Data Sciences, Pfizer
Artificial intelligence is bringing a brand new set of tools to the Clinical Data Sciences toolbox. These tools offer important opportunities to help transform our processes as we seek to cut both time and resources required to process increasing volumes of data, using risk-based approaches. However, they also come with pitfalls and limitations which must be understood to effectively de-risk their implementation.
People
Brian Thornton, Senior Vice President, Biometrics, Spaulding Clinical Research, LLC
The impact of AI and ML on Clinical Data Management professionals in pharmaceutical research is multifaceted. While these technologies have the potential to enhance efficiency, decision-making, and collaboration, they also bring about changes in job roles and require employees to adapt to new ways of working.
Regulatory
Eboni Russell, Executive Director and Global Head of Clinical Data Management FSP, Fortrea
You will hear more on the current regulatory thinking about emerging AI/ML capabilities, and you will have the chance to directly engage with regulatory leaders.
SCDM Leadership Forum
You can apply to attend the Leadership Forum or directly register with your code if you received a personal invitation.
Please note there is an additional fee of $500 to attend the Leadership Forum.
